Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 166 | 204 | N/A |
| Receivables | 10 | 8 | N/A |
| TOTAL | $209 | $266 | $N/A |
| Non-Current Assets | |||
| PPE Net | 14 | 16 | N/A |
| TOTAL | $14 | $16 | $N/A |
| Total Assets | $223 | $282 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,034 | 1,812 | 0 |
| TOTAL | $1,067 | $1,812 | $N/A |
| Non-Current Liabilities | |||
| Deferred Revenues | 33 | N/A | N/A |
| Other Non-Current Liabilities | 389 | 0 | 0 |
| TOTAL | $389 | $N/A | $N/A |
| Total Liabilities | $1,456 | $1,812 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 36,375 | 35,178 | N/A |
| Retained earnings | -44,484 | -42,890 | N/A |
| Other shareholders' equity | 1,695 | 1,720 | 0 |
| TOTAL | $-1,233 | $-1,530 | $N/A |
| Total Liabilities And Equity | $223 | $282 | $0 |